| 284 | 2 | 147 |
| 下载次数 | 被引频次 | 阅读次数 |
宫颈癌是世界上发病率和死亡率位居第四的肿瘤，也是中国女性最常见的肿瘤之一。为改善宫颈癌患者的预后，提高患者的生存率，迫切需要寻找新的治疗靶点及预后标志物。近年来，研究发现长链非编码RNA(LncRNA)在宫颈癌、正常组织和良性肿瘤中的表达存在差异，提示LncRNA可能参与调节宫颈癌的发生和发展。目前已发现数种LncRNA与宫颈癌的发生、侵袭和进展有关。本文拟对LncRNA在宫颈癌发生发展中的具体作用、分子机制以及潜在临床应用作一综述。
Abstract：[1] Bray F,Ferlay J,Soerjomataram I,et al.Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA:A Cancer J Clin,2018,68(6):394-424.
[2] Aalijahan H,Ghorbian S.Long non-coding RNAs and cervical cancer[J].Exp Mol Pathol,2019,106:7-16.
[3] Zeng H M,Chen W Q,Zheng R S,et al.Changing cancer survival in China during 2003-15:a pooled analysis of 17 population-based cancer registries[J].Lancet Glob Heal,2018,6(5):e555-e567.
[4] Wang K C,Chang H Y.Molecular mechanisms of long noncoding RNAs[J].Mol Cell,2011,43(6):904-914.
[5] Dou X Q,Zhou Q,Wen M X,et al.Long noncoding RNA FOXD2-AS1 promotes the malignancy of cervical cancer by sponging MicroRNA-760 and upregulating hepatoma-derived growth factor[J].Front Pharmacol,2019,10:1700.
[6] Wu F,Sui Y J,Wang Y H,et al.Long noncoding RNA SNHG7,a molecular sponge for microRNA-485,promotes the aggressive behavior of cervical cancer by regulating PAK4[J].Oncotargets Ther,2020,13:685-699.
[7] Xu D Z,Dong P X,Xiong Y,et al.MicroRNA-361-mediated inhibition of HSP90 expression and EMT in cervical cancer is counteracted by oncogenic lncRNA NEAT1[J].Cells,2020,9(3):632.
[8] Yuan L Y,Zhou M,Lv H,et al.Involvement of NEAT1/miR-133a axis in promoting cervical cancer progression via targeting SOX4[J].J Cell Physiol,2019,234(10):18985-18993.
[9] Xie Q X,Lin S N,Zheng M J,et al.Long noncoding RNA NEAT1 promotes the growth of cervical cancer cells via sponging miR-9-5p[J].Biochem Cell Biol,2019,97(2):100-108.
[10] Dong J,Su M,Chang W,et al.Long non-coding RNAs on the stage of cervical cancer (Review)[J].Oncol Rep,2017,38(4):1923-1931.
[11] Hosseini E S,Meryet-Figuiere M,Sabzalipoor H,et al.Dysregulated expression of long noncoding RNAs in gynecologic cancers[J].Mol Cancer,2017,16(1):1-13.
[12] Jiang Y,Li Y H,Fang S J,et al.The role of MALAT1 correlates with HPV in cervical cancer[J].Oncol Lett,2014,7(6):2135-2141.
[13] Yang L,Bai H S,Deng Y,et al.High MALAT1 expression predicts a poor prognosis of cervical cancer and promotes cancer cell growth and invasion[J].Eur Rev Med Pharmacol Sci,2015,19(17):3187-3193.
[14] Zhao D Y,Zhang H,Long J X,et al.LncRNA SNHG7 functions as an oncogene in cervical cancer by sponging miR-485-5p to modulate JUND expression[J].Oncotargets Ther,2020,13:1677-1689.
[15] Zeng J,Ma Y X,Liu Z H,et al.LncRNA SNHG7 contributes to cell proliferation,invasion and prognosis of cervical cancer[J].Eur Rev Med Pharmacol Sci,2019,23(21):9277-9285.
[16] Wang L Y,Li R L,Guo M,et al.Long noncoding RNA HULC promoter polymorphism rs1041279 is associated with an increased risk of cervical squamous cell carcinoma[J].Reprod Sci,2020,27(1):93-99.
[17] Lu W J,Wan X B,Tao L M,et al.Long non-coding RNA HULC promotes cervical cancer cell proliferation,migration and invasion via miR-218/TPD52 axis[J].Oncotargets Ther,2020,13:1109-1118.
[18] Yu J J,Wang Y,Dong R F,et al.Circulating microRNA-218 was reduced in cervical cancer and correlated with tumor invasion[J].J Cancer Res Clin Oncol,2012,138(4):671-674.
[19] Wang Y,Han X Y,Qiu H F,et al.MicroRNA-218 enhances the radiosensitivity of human cervical cancer via promoting radiation induced apoptosis[J].Int J Med Sci,2014,11(7):691-696.
[20] Tornesello M L,Faraonio R,Buonaguro L,et al.The role of microRNAs,long non-coding RNAs,and circular RNAs in cervical cancer[J].Front Oncol,2020,10:150.
[21] Al-Rugeebah A,Alanazi M,Parine N R.MEG3:an oncogenic long non-coding RNA in different cancers[J].Pathol Oncol Res,2019,25(3):859-874.
[22] Zhang J,Gao Y L.Long non-coding RNA MEG3 inhibits cervical cancer cell growth by promoting degradation of P-STAT3 protein via ubiquitination[J].Cancer Cell Int,2019,19:175.
[23] Dai S G,Guo L L,Xia X,et al.Long non-coding RNA WT1-AS inhibits cell aggressiveness via miR-203a-5p/FOXN2 axis and is associated with prognosis in cervical cancer[J].Eur Rev Med Pharmacol Sci,2019,23(2):486-495.
[24] Cui L,Nai M,Zhang K,et al.LncRNA WT1-AS inhibits the aggressiveness of cervical cancer cell via regulating p53 expression via sponging miR-330-5p[J].Cancer Manag Res,2019,11:651-667.
[25] Zhao L P,Li R H,Han D M,et al.Independent prognostic factor of low-expressed lncRNA ZNF667-AS1 for cervical cancer and inhibitory function on the proliferation of cervical cancer[J].Eur Rev Med Pharmacol Sci,2017,21(23):5353-5360.
[26] Li Y J,Yang Z,Wang Y Y,et al.Long noncoding RNA ZNF667-AS1 reduces tumor invasion and metastasis in cervical cancer by counteracting microRNA-93-3p-dependent PEG3 downregulation[J].Mol Oncol,2019,13(11):2375-2392.
[27] Song M S,Salmena L,Pandolfi P P.The functions and regulation of the PTEN tumour suppressor[J].Nat Rev Mol Cell Biol,2012,13(5):283-296.
[28] Alimonti A,Carracedo A,Clohessy J G,et al.Subtle variations in Pten dose determine cancer susceptibility[J].Nat Genet,2010,42(5):454-458.
[29] Fan Y,Sheng W,Meng Y,et al.LncRNA PTENP1 inhibits cervical cancer progression by suppressing miR-106b[J].Artif Cells Nanomed Biotechnol,2020,48(1):393-407.
[30] Poliseno L,Salmena L,Zhang J W,et al.A coding-independent function of gene and pseudogene mRNAs regulates tumour biology[J].Nature,2010,465(7301):1033-1038.
基本信息:
中图分类号:R737.33
引用信息:
[1]杨月楠,黄乔,杨自为.LncRNA与宫颈癌的研究进展[J].巴楚医学,2022,5(04):117-120.
基金信息:
中国博士后基金面上项目(No:2017M612816); 宜昌市医疗卫生科研项目(No:A19-301-01)
2022-12-26
2022-12-26